These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Basic aspects of neuroimmunology as they relate to immunotherapeutic targets: present and future prospects. Dalakas MC Ann Neurol; 1995 May; 37 Suppl 1():S2-13. PubMed ID: 8968213 [TBL] [Abstract][Full Text] [Related]
28. The continuous discovery of autoantigens in endocrine organ-specific autoimmunity: do they help us to understand pathogenesis? Fierabracci A; Bottazzo GF Springer Semin Immunopathol; 2002 Dec; 24(3):243-59. PubMed ID: 12503053 [No Abstract] [Full Text] [Related]
29. Possible mechanisms of autoantibody production and the connection of viral infections in human autoimmune diseases. Yamamoto K Tohoku J Exp Med; 1994 May; 173(1):75-82. PubMed ID: 7528946 [TBL] [Abstract][Full Text] [Related]
30. The viral enterprises in autoimmunity: conversion of target cells into de novo APCs is the presage to autoimmunity. Temajo NO; Howard N Autoimmun Rev; 2012 Jul; 11(9):653-8. PubMed ID: 22122867 [TBL] [Abstract][Full Text] [Related]
31. Asthma as a paradigm for autoimmune disease. Rottem M; Shoenfeld Y Int Arch Allergy Immunol; 2003 Nov; 132(3):210-4. PubMed ID: 14646381 [TBL] [Abstract][Full Text] [Related]
32. Depletion of CD8+ cells exacerbates organ-specific autoimmune diseases induced by CD4+ T cells in semiallogeneic hosts with MHC class II disparity. Saitoh T; Ikarashi Y; Ito S; Watanabe H; Fujiwara M; Asakura H J Immunol; 1990 Nov; 145(10):3268-75. PubMed ID: 2121823 [TBL] [Abstract][Full Text] [Related]
33. Genetic background and environment contribute synergistically to the onset of autoimmune diseases. Luppi P; Rossiello MR; Faas S; Trucco M J Mol Med (Berl); 1995 Aug; 73(8):381-93. PubMed ID: 8528740 [TBL] [Abstract][Full Text] [Related]
34. The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targeting. Baert L; Manfroi B; Casez O; Sturm N; Huard B J Autoimmun; 2018 Dec; 95():179-190. PubMed ID: 30385081 [TBL] [Abstract][Full Text] [Related]
35. Myasthenia Gravis: paradox versus paradigm in autoimmunity. Berrih-Aknin S J Autoimmun; 2014 Aug; 52():1-28. PubMed ID: 24934596 [TBL] [Abstract][Full Text] [Related]
36. Pathogenic mechanisms in autoimmune diseases. Rose NR Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 2):S7-16. PubMed ID: 2676277 [TBL] [Abstract][Full Text] [Related]
37. Role of dendritic cells in the induction and maintenance of autoimmune diseases. Ludewig B; Odermatt B; Ochsenbein AF; Zinkernagel RM; Hengartner H Immunol Rev; 1999 Jun; 169():45-54. PubMed ID: 10450507 [TBL] [Abstract][Full Text] [Related]
38. A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. Steinman L Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2253-6. PubMed ID: 8637858 [TBL] [Abstract][Full Text] [Related]
39. Breakdown of self-tolerance and the pathogenesis of autoimmunity. Ring GH; Lakkis FG Semin Nephrol; 1999 Jan; 19(1):25-33. PubMed ID: 9952278 [TBL] [Abstract][Full Text] [Related]
40. Viral infections in the pathogenesis of autoimmune diseases: focus on type 1 diabetes. Richer MJ; Horwitz MS Front Biosci; 2008 May; 13():4241-57. PubMed ID: 18508508 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]